SJS Investment Consulting’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19K Buy
220
+207
+1,592% +$794 ﹤0.01% 1966
2026
Q1
$30 Buy
+13
New +$41 ﹤0.01% 2320
2024
Q4
Sell
-6
Closed -$170 1640
2024
Q3
$170 Buy
6
+4
+200% +$103 ﹤0.01% 1529
2024
Q2
$39 Hold
2
﹤0.01% 1630
2024
Q1
$66 Buy
2
+1
+100% +$32 ﹤0.01% 1596
2023
Q4
$34 Sell
1
-9
-90% -$255 ﹤0.01% 1602
2023
Q3
$273 Buy
10
+5
+100% +$139 ﹤0.01% 1394
2023
Q2
$152 Sell
5
-1
-17% -$32 ﹤0.01% 1455
2023
Q1
$195 Buy
6
+1
+20% +$32 ﹤0.01% 1367
2022
Q4
$140 Buy
5
+1
+25% +$29 ﹤0.01% 1458
2022
Q3
$0 Buy
+4
New +$141 ﹤0.01% 1184
2022
Q1
$0 Buy
+1
New +$26 ﹤0.01% 887

Other funds holding EVH

SJS Investment Consulting's EVH Position: Q2 2026 in Review

SJS Investment Consulting increased its Evolent Health (EVH) stake by 1,592% in Q2 2026, buying an estimated $794 and bringing the position to 220 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

SJS Investment Consulting first reported a position in EVH in Q1 2022 and has held it in 12 quarters since. 35 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • SJS Investment Consulting held 220 shares of Evolent Health worth $1.19K as of Q2 2026.
  • SJS Investment Consulting bought 207 Evolent Health shares in Q2 2026, an estimated $794.
  • Evolent Health made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1966 holding.
  • SJS Investment Consulting first reported a position in Evolent Health in Q1 2022 and has held it in 12 quarters since.
  • 35 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.